Ion transport and oxidative metabolism. I. The inhibition of mitochondrial oxidative metabolism by the unsubstituted aromatic sulfonamides (carbonic anhydrase inhibitors).
D000086:Acetazolamide / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology*; D004285:Dogs; D005665:Furosemide / Q000494:pharmacology*; D005753:Gastric Mucosa / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D007668:Kidney / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000378:metabolism; D009206:Myocardium / Q000166:cytology / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D013449:Sulfonamides / Q000494:pharmacology*; D013696:Temperature
D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D005665:Furosemide; D000086:Acetazolamide